Status:
COMPLETED
FERtility After Therapy With Intensive Lymphoma in Young Women: LNH-03 1B, LNH-03 2B, LNH-07 3B, GAINED Follow-up
Lead Sponsor:
The Lymphoma Academic Research Organisation
Conditions:
DLBCL - Diffuse Large B Cell Lymphoma
Eligibility:
FEMALE
18-38 years
Brief Summary
The FERTILE study is a retrospective cohort study evaluating fertility after intensive treatment with RCHOP14/RCHOP21 or ACVBP in young patients with diffuse large B-cell lymphoma treated in clinical ...
Detailed Description
The FERTILE study is a retrospective cohort study evaluating fertility after intensive treatment with RCHOP14/RCHOP21 or ACVBP in young patients (≤ 38 years) with diffuse large B-cell lymphoma treated...
Eligibility Criteria
Inclusion
- The subjects are women
- Participation in one of the following clinical trials: LNH 03 1B or LNH 03 2B or LNH 07 3B or GAINED
- Age at initial diagnosis between 18 years and 38 years inclusive, which has allowed their inclusion in the clinical trial
- Treated with R-ACVBP or R-CHOP14/R-CHOP21 in these clinical trials
- No relapse of their diffuse large B-cell lymphoma
- Possible use of stem cell transplantation during clinical trials
- Subjects are still alive today
Exclusion
- Subjects died
- Subjects lost to follow-up
Key Trial Info
Start Date :
September 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 15 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06592846
Start Date
September 30 2024
End Date
January 15 2025
Last Update
July 22 2025
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
CH d'Avignon - Hôpital Henri Duffaut
Avignon, France, 84000
2
Institut d'Hématologie de Basse Normandie (IHBN)
Caen, France, 14033
3
APHP - Hôpital Henri Mondor
Créteil, France, 94010
4
CHU de Dijon - Hôpital François Mitterand
Dijon, France, 21079